RIGL
NASDAQ · Biotechnology
Rigel Pharmaceuticals Inc
$51.29
+2.43 (+4.97%)
Open$50.57
Previous Close$48.86
Day High$51.74
Day Low$49.23
52W High$52.24
52W Low$24.95
Volume—
Avg Volume201.0K
Market Cap975.37M
P/E Ratio3.03
EPS$16.04
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+5.5% upside
Current
$51.29
$51.29
Target
$54.10
$54.10
$39.68
$54.10 avg
$74.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 306.18M | 227.17M | 385.25M |
| Net Income | 381.86M | 254.99M | -63,461,041 |
| Profit Margin | 124.7% | 118.5% | -16.5% |
| EBITDA | 133.05M | 93.78M | -108,813,206 |
| Free Cash Flow | — | — | -71,858,369 |
| Rev Growth | +34.8% | +34.8% | +12.7% |
| Debt/Equity | 0.13 | 0.13 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |